Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence

Gianluigi Savarese, Ana-Maria Vintila, Luca Degli Esposti, Melania Dovizio, Julien Magne, Marta Nugnes, Chiara Veronesi, Jacek Wolf, Stefano Masi

Open source

DOI
10.1007/s40256-026-00818-4
Published
2026-08-07
Container
American Journal of Cardiovascular Drugs
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40256-026-00818-4,
  title = {Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence},
  author = {Gianluigi Savarese and Ana-Maria Vintila and Luca Degli Esposti and Melania Dovizio and Julien Magne and Marta Nugnes and Chiara Veronesi and Jacek Wolf and Stefano Masi},
  year = {2026},
  journal = {American Journal of Cardiovascular Drugs},
  doi = {10.1007/s40256-026-00818-4},
  url = {https://doi.org/10.1007/s40256-026-00818-4}
}

RIS

TY  - JOUR
TI  - Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence
AU  - Gianluigi Savarese
AU  - Ana-Maria Vintila
AU  - Luca Degli Esposti
AU  - Melania Dovizio
AU  - Julien Magne
AU  - Marta Nugnes
AU  - Chiara Veronesi
AU  - Jacek Wolf
AU  - Stefano Masi
PY  - 2026
JO  - American Journal of Cardiovascular Drugs
DO  - 10.1007/s40256-026-00818-4
UR  - https://doi.org/10.1007/s40256-026-00818-4
ER  - 

APA

Savarese, G., Vintila, A., Esposti, L. D., Dovizio, M., Magne, J., Nugnes, M., Veronesi, C., Wolf, J., & Masi, S. (2026). Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00818-4

Source records